General Catalyst Group Management as of June 30, 2026
Portfolio Holdings for General Catalyst Group Management
General Catalyst Group Management holds 14 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arrivent Biopharma (AVBP) | 27.5 | $52M | 1.5M | 34.74 | |
| Parabilis Medicines | 23.2 | $44M | 1.6M | 27.37 | |
| Maplebear (CART) | 17.9 | $34M | 711k | 47.35 | |
| Maze Therapeatics (MAZE) | 16.4 | $31M | 1.0M | 29.84 | |
| Odyssey Therapeutics Common Stock | 8.0 | $15M | 810k | 18.71 | |
| Eikon Therapeutics (EIKN) | 2.1 | $4.0M | 305k | 13.05 | |
| Fractyl Health (GUTS) | 2.1 | $3.9M | 4.9M | 0.79 | |
| Ethos Technologies Cl A (LIFE) | 0.7 | $1.3M | 74k | 18.14 | |
| Coupang Cl A (CPNG) | 0.5 | $950k | 55k | 17.37 | |
| Amazon (AMZN) | 0.5 | $925k | 3.9k | 238.34 | |
| Meta Platforms Cl A (META) | 0.4 | $744k | 1.3k | 563.29 | |
| Doordash Cl A (DASH) | 0.3 | $526k | 2.9k | 184.53 | |
| Carvana Cl A (CVNA) | 0.2 | $426k | 6.5k | 65.82 | |
| Figma Class A Com Stk (FIG) | 0.1 | $269k | 15k | 18.09 |
